The combination of hyaluronic acid, chondroitin sulfate, glucosamine and methysulfonylmethane (MSM) help maintain joint health and mobility in horses.
This privacy statement discloses what information we gather about you when you visit our Site and describes how we use that information. Our policy is to keep the personal information we receive from our Site completely confidential and used solely for internal purposes. We will not share your personal information with any other parties.
Use of the Product Information on this Website
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with healthcare provider, considering the unique characteristics of the patient.
Collection of your Personal Information:
The personal information we collect may include your name, title, company or organization name, email, phone. We may collect certain information about your visit, such as type of browser you use; the date and time you access the Site; the pages that you access while at the Site and the Internet address of the Web site from which you linked directly to our Site. This information is used to help improve the Site and administer the Site.
Use of your Personal Information:
The personal information collected on this Site will be used to provide the services you have requested.
We may use your personal information to provide you with important information about the product or service that you are using, including critical updates and notifications. Additionally, we may send you information about other products and services.
We may occasionally modify this privacy statement. All such changes will be reflected on this web page.
Veta-K1® is indicated in coagulation disorders and to counter hypothrombinemia (impaired blood clotting) induced by ingestion of anticoagulant rodenticides.
Equimax® Paste is a broad spectrum parasite, bot and tapeworm control. It is safe to use in foals as early as 4 weeks of age, pregnant and lactating mares, and breeding stallions.
Butatron® tablets are indicated for the management of musculoskeletal conditions such as osteoarthritis, particularly where continued mobility is considered desirable.
Bimeda Equine is proud to promote best practices and targeted worming regimens, to help protect both today’s horses and future generations.
To find out more, click here to visit our Best Practice Advice section.
To view and download our materials, such as our Horse Owner’s Guide To Worming and visit out Library Section.